Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE

Abstract
Background Enoxaparin treatment is associated with a 20% reduction in clinical events during the acute phase of management of patients with unstable

This publication has 0 references indexed in Scilit: